Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter TrialMichael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
JCO Oncology Practice|May 12, 2025
High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple MyelomaMark Aaron Fiala, Mengmeng Ji, Michael Slade, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid LeukemiaJoan How, Michael Slade, Khoan Vu, et al.
Cancer Discovery|July 9, 2024
Rational Protein Engineering to Enhance MHC-Independent T-cell ReceptorsJu-Fang Chang, Jack H Landmann, Tien-Ching Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2016
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Jesse Keller, Michael Slade, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic LeukemiaSamer A Srour, Denái R Milton, Asad Bashey, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|July 25, 2022
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysisArmin Ghobadi, Michael Slade, Hagop Kantarjian, et al.
Blood|May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Pageof 4